Israelis attend alternative-energy meeting

The French participants acknowledged the potential of Israeli companies in this field.

March 19, 2009 07:52
Israelis attend alternative-energy meeting

solar 88. (photo credit: )


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Executives from Israeli, French and German alternative-energy companies met in Paris this week to discuss cooperation opportunities. The second in a series of meetings was organized by the Israeli Embassy in Paris. Officials from Soleil, Delek Energy and Israel Corp., Dr. Isaac Berzin and financial advisers met with their counterparts from French and German companies EDF, Concentrix, Areva Renewable, the Rothschild Bank, Alstom and Schneider Electric Ventures. They discussed potential cooperation in light of the global financial crisis and the rise of renewable-energy initiatives. The French participants acknowledged the potential of Israeli companies in this field.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection